Rather odd that the story state CNN covered CytoDyn's report, yet today ran an article about great promise of overlooked potential of mAbs and covered Lilly and Regeneron extensively in the article but not a peep about leronlimab. CNN can be truly pathetic with major holes in what pretends to be thorough coverage and all on the side of their BP buddies who buy ads there all day long. MSM bias knows no limits.